scholarly journals Improving Blood Pressure Control in Over-the-Road Truck Drivers: Is Provision of Medication Therapy Management by Pharmacists Feasible?

2015 ◽  
Vol 6 (1) ◽  
Author(s):  
Keri D. Hager ◽  
Benjamin D. Aronson ◽  
Reid C. Smith ◽  
David Parra ◽  
Michael Swanoski
Keyword(s):  
Blood Pressure ◽  
Blood Pressure Control ◽  
Pressure Control ◽  
Medication Therapy Management ◽  
Truck Drivers ◽  
Morbidity And Mortality ◽  
Therapy Management ◽  
The Road ◽  
Medication Therapy ◽  
On The Road

Purpose This pilot sought to determine feasibility of studying the impact on hypertension in over-the-road truck drivers who met with pharmacists for Medication Therapy Management (MTM) compared to those who did not. Design/methodology/approach Drivers were randomly assigned to control or treatment (MTM) group for 52 weeks. Drivers assigned to the MTM arm could receive services in person or via secure videoconferencing technology located in a private space at the trucking company. All subjects were provided education and received a blood pressure monitor and log for recording daily blood pressures. Findings Eleven drivers enrolled and seven drivers completed the study. The primary barriers to participation included unpredictable driver schedules and lack of access to MTM provider while on the road. Research limitations/implications This pilot study was limited by small sample size. Pharmacists were not available to meet with truckers "on demand." Therefore, researchers are encouraged to test alternate opportunities to increase enrollment of drivers in studies and access to MTM services while drivers are on the road. Practical implications Hypertension is the second highest health-related cost burden, and over-the-road truck drivers have unique challenges that can make it difficult to attain blood pressure control. Pharmacist-provided MTM has been shown to improve blood pressure control. Improving access to MTM, perhaps using a national network of pharmacists or technology from the road, may decrease morbidity and mortality in drivers. Originality/value This paper fulfills an identified need to study how to improve driver access to care to reduce cardiovascular-related morbidity and mortality.   Type: Clinical Experience

scholarly journals Pengaruh Medication Therapy Management (MTM) terhadap Outcome Klinik dan Kualitas Hidup Pasien Hipertensi di Puskesmas Kota Yogyakarta

2021 ◽  
Vol 10 (4) ◽  
Author(s):  
Tiara Dewi Salindri Pratama ◽  
Nanang Munif Yasin ◽  
Susi Ari Kristina
Keyword(s):  
Quality Of Life ◽  
Blood Pressure ◽  
Clinical Outcomes ◽  
Medication Therapy Management ◽  
Wilcoxon Test ◽  
P Value ◽  
Hypertensive Patients ◽  
Therapy Management ◽  
Medication Therapy

Medication therapy management (MTM), is a service model aimed at helping general health problems by preventing morbidity and mortality. Hypertension is a non-communicable disease which is a serious health problem which requires long-term therapy.  This study aims to see the effect of MTM on clinical Outcomes and quality of life of patients in hypertensive patients. This type of research is a quasi experimental one group with a pretest-posttest design. Analysis using paired sample t-test and Wilcoxon test with a significance used P <0,05. Respondents were 70 people, 67,1% were women. The characteristics of the majority age are 55-64 years with a percentage of 51,4%, the majority of education level is high school with 42,8%, non-civil servant jobs with a percentage of 45,7%, the length of diagnosis is dominated by 1-10 years (77,1%) and comorbidities diabetes mellitus occurred the most (10,0%). The results showed that the quality of life increased from before getting MTM 54,4 ± 8,9 and after MTM intervention 60,4 ± 6,6 (P value <0,001). Clinical outcome from systolic 159,2 ± 8,9 mmHg and diastolic 103,8 ± 8,0 mmHg before MTM to 144,1 ± 14,4 mmHg for systolic and 89,7 ± 8,8 mmHg for diastolic with p value <0,001 (p <0,05) for systolic blood pressure and p value: 0,016 (p <0,05) after receiving MTM intervention. Medication Therapy Management (MTM) has a significant influence on improving the quality of life and clinical Outcomes of hypertensive patients. The higher the quality of life of patients, blood pressure becomes more controlled.

scholarly journals Key components of success in a randomized trial of blood pressure telemonitoring with medication therapy management pharmacists

2018 ◽  
Vol 58 (6) ◽  
pp. 614-621 ◽  
Author(s):  
MarySue Beran ◽  
Stephen E. Asche ◽  
Anna R. Bergdall ◽  
Benjamin Crabtree ◽  
Beverly B. Green ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Randomized Trial ◽  
Medication Therapy Management ◽  
Therapy Management ◽  
Medication Therapy

scholarly journals Impact of a Medication Therapy Management Clinic on Glycosylated Hemoglobin, Blood Pressure, and Resource Utilization

2018 ◽  
Vol 53 (1) ◽  
pp. 13-20 ◽  
Author(s):  
Jessica J. Tilton ◽  
Mansi G. Edakkunnathu ◽  
Kellyn M. Moran ◽  
Anna Markel Vaysman ◽  
Jessica L. DaPisa ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Low Income ◽  
Hospital Admissions ◽  
Glycosylated Hemoglobin ◽  
Medication Management ◽  
Medication Therapy Management ◽  
Therapy Management ◽  
Medication Therapy ◽  
Institutional Review ◽  
Patients With Diabetes

Background: Medication therapy management is widely promoted to improve care. However, few well-controlled studies have evaluated its impact. Objectives: We evaluated whether enrollment in a comprehensive medication therapy management clinic (MTMC) was associated with improved 12-month outcomes. Methods: This institutional review board approved study was a retrospective controlled cohort study in an academic health center serving low-income, African American and Latino populations. Between 2001 and 2011 MTMC patients were matched to control patients by age, gender, and comorbidities. Outcomes were mean change in glycosylated hemoglobin (A1C), diastolic (DBP) and systolic blood pressure (SBP), and emergency department (ED) and hospital admissions at 6 and 12 months. A difference-in-difference analysis was conducted for each outcome of interest, adjusting for observed, unmatched confounders. Results: Patients with diabetes and receiving MTMC had greater A1C improvements, compared with controls, of 0.54% (P = 0.0067) at 6 months and 0.63% (P = 0.0160) at 12 months. At 6 months, SBP and DBP decreased in MTMC patients by 6.5 mm Hg (P = 0.0108) and 3.8 mm Hg (P = 0.0136) more than controls, respectively. At 12 months, those receiving MTMC services had SBP and DBP decreases, respectively, of 8.2 mm Hg (P = 0.0018) and 1.7 mm Hg (P = 0.2691) compared with controls. ED and hospital visits were not statistically significantly different between groups. Conclusion and Relevance: This MTMC potentially improved outcomes for referred patients in whom target goals were difficult to achieve and can serve as a model for other similar medication management programs.

Sign in / Sign up

Export Citation Format

Share Document